Hewlett-Packard defibrillator falls foul of UK power and receives hazard hazard warning
This article was originally published in Clinica
The UK's Medical Devices Agency has issued a hazard warning notice to Hewlett-Packard over two of its best-selling defibrillators, the CodeMaster XE and the CodeMaster XL+ defibrillator/monitor. The MDA would not comment on what the nature of the fault was. However, the company says it has identified the failure of the device as traceable back to the unstable voltage in the UK power supply.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.